TotalMarketCap

Annexon

ANNXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$755.473 M

$3.99 -7.97%

Close of 6 Nov 2026

As of 6 Nov 2026, Annexon (ANNX) has a market capitalization of $755.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$206.7M

Loss-making

Shares outstanding

149,362,800

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #160CryoportCYRX$813.4M
  2. #161AlumisALMS$756.5M
  3. #162AnnexonANNX$755.5M
  4. #163ArdelyxARDX$750.3M
  5. #164Lexicon PharmaceuticalsLXRX$723.1M

What if Annexon were worth as much as…

Open the what-if tool →

Gold $28.2T

$148,945.05

Per share 37,376× higher

Bitcoin $1.53T

$8,059.16

Per share 2,022× higher

Apple $5.02T

$26,457.46

Per share 6,639× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Annexon are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.